Draft Programme

17:00 – 19:00 Registration Opens
18:00 – 19:00 Pre-Symposium Canapes preceding Takeda Symposium
19:00 – 20:00 Symposium: Takeda
Chair: Dr Hannes Koornhof
Clinical case Presentation – Dr Zeenat Moorad
Hodgkin Lymphoma: Making the Most with What We Have: Prof Martin Hutchings
07:00 Registration and Exhibition Open
08:00 – 08:10 Welcome
08:10 – 09:25 Session 1 – Chair: Prof Vernon Louw Sponsored by: Novartis
Chronic Myeloid Leukemia Session

  • Case Presentation – Dr Jaimendra Singh
  • Prof Tim Hughes, University of Adelaide, Royal Adelaide Hospital

Panel Discussion; Q&A: Prof Louw, Prof Hughes, Dr Singh

09:25 – 09:55 Tea
09:55 – 10:05 Welcome to the new generation of haematologists
10:05 – 10:45 Standing on the Shoulders of Giants
10:45-12:00 Session 2 – Chair: Dr Karen Gunther Sponsored by: Aspen Pharmacare
Acute Lymphoblastic Leukemia Session

  • Managing acute lymphoblastic leukemia in adults – Dr Matthew Seftel, University of British Columbia Canadian Blood Services, Vancouver
  • Lymphoid NGS and implications for treatment decisions in acute lymphoblastic leukemia – Dr Theo Gerdener

Panel Discussion; Q & A: Dr De Witt, Dr Seftel, Dr Gerdener

12:00 – 13:00 Lunch
13:00-14:40 Session 3 – Chair: Dr David Brittain Sponsored by: Roche and Takeda Nurses Symposium
13:00 – 17:00
Click to view detailed programme
Lymphoma session

  • Evolving management of relapsed/refractory diffuse large B-cell lymphoma – Dr Wendy Osborne, Freeman Hospital, Newcastle Upon Tyne
  • Panel Discussion; Q&A: Dr Brittain, Dr Osborne, Dr Hutchings
  • First line management of Hodgkin lymphoma – Dr Martin Hutchings, Rigshospitalet, Copenhagen
  • Panel Discussion; Q&A: Dr Brittain, Dr Osborne, Dr Hutchings
14:40 – 15:00 Tea
15:00 – 16:30 Session 4 – Chair: Dr Jacques Malherbe
Proffered papers: 6 oral presentations

  1. Dr Nokubonga Vundla
    Trends in clinical presentation and treatment outcomes in a South African thrombotic thrombocytopenic purpura cohort.
  2. Ms Babalwa Yekelo
    Aqueous extracts of Dodonaea viscosa induce potent and selective cytotoxicity in diffuse large B-cell lymphoma cells.
  3. Dr Obey Mawire
    Post-transplant lymphoproliferative disorders: a retrospective analysis of a single renal transplant centre.
  4. Dr Tennis Potelwa
    The diagnostic outcomes of a surgical lymph node excision biopsy service in an HIV and TB endemic region.
  5. Dr Shaun Grobler
    Sample Senescence or Atypical Chronic Lymphocytic Leukemia? Effects of Pre-analytical Variables on the Flow cytometric Diagnosis of CLL.
  6. Ms Anthara Vivek
    A precision medicine approach to sickle cell disease by targeting the adhesion interactome.
16:30 – 17:30 Poster Session
17:00 – 18:30 SACHaS AGM
19:30 Conference Dinner
07:30 Exhibition Opens
08:00 – 09:15 Breakfast Symposium: Roche (High Grade B-cell Lymphoma) – Chair: Prof Estelle Verburgh

High Grade B-cell Lymphoma

  • Case Presentation – Dr Hannes Koornhof
  • First line therapy of diffuse large B-cell lymphoma – Dr Wendy Osborne, Freeman Hospital, Newcastle University

Panel Discussion; Q&A: Prof Verburgh, Dr Koornhof, Dr Osborne

09:15 – 09:35 Tea
09:35 – 10:50 Session 6 – Chair: Dr Andrew McDonald

Thrombosis Update

  • Dr Piet Wessels

Panel Discussion; Q&A: Dr McDondald, Dr Wessels

10:50 – 12:05 Session 7 – Chair: Dr Michael Cass Sponsored by: AstraZeneca

Mantle Cell Lymphoma – What’s New?

  • Case Presentation – Dr Michael Cass
  • Dr Michael Wang, Anderson Cancer Center, Houston, Texas

Panel Discussion; Q & A: Dr Wang, Dr Cass

12:05 – 12:15 Conference Closure – Dr Hannes Koornhof